Oncternal Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Oncternal Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$87K, a 108% decline year-over-year.
  • Oncternal Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $1.07M, a 88.9% decline from 2022.
  • Oncternal Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.58M, a 1453% increase from 2021.
  • Oncternal Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $617K, a 99.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.07M -$8.51M -88.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $9.58M +$8.96M +1453% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $617K -$114M -99.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $114M +$114M +761107% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
2019 $15K -$17.9M -99.9% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
2018 $17.9M -$27.6M -60.7% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $45.5M +$32M +237% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $13.5M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2014 $63.3M +$62.1M +5095% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-24
2013 $1.22M +$1.22M +40533% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-15
2012 $3K -$48.9M -100% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-16
2011 $49M +$8.74M +21.7% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-12
2010 $40.2M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.